Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-03-22 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB SA_Board of Directors report_12_2023 EN - Final (web).pdf
Annual Report Classification · 1% confidence The document is titled 'Annual report of the Board of Directors for the financial year ended 31 December 2023'. It contains detailed financial data, including balance sheet items, income statement analysis, dividend proposals, and management commentary on the company's performance. While it references the 'UCB Group Integrated Annual Report 2023' for further details, this specific document serves as the statutory report of the Board of Directors for the parent company (UCB SA/NV), providing substantive financial analysis and results for the fiscal year. Therefore, it qualifies as an Annual Report (10-K). FY 2023
2024-03-22 English
Remuneration Policy 2024_FR_FINAL.pdf
Remuneration Information Classification · 1% confidence The document is titled "POLITIQUE DE RÉMUNÉRATION D'UCB EN 2024" (UCB Remuneration Policy for 2024) and explicitly discusses the philosophy and policies applicable to the compensation of the Executive Committee and the Board of Directors. It details remuneration components, fixed emoluments, variable pay, and stock compensation for directors and executives. This content directly aligns with the definition of a Remuneration Information document, which corresponds to the DEF 14A filing type in the provided schema, even though the document is in French. The text mentions that the policy is subject to adoption by the General Shareholders' Meeting, confirming its nature as a governance/remuneration disclosure document.
2024-03-22 French
Remuneration Policy 2024_NL_FINAL.pdf
Remuneration Information Classification · 1% confidence The document is titled "UCB BEZOLDIGINGSBELEID VANAF 2024" (UCB Remuneration Policy from 2024). It explicitly discusses the remuneration philosophy and policy applicable to the Executive Committee and the Board of Directors, referencing compliance with the Belgian Companies Code and the 2020 Corporate Governance Code. It details fixed compensation, attendance fees, variable remuneration, and share-based compensation for board members and committee members. This content directly relates to the compensation and remuneration practices of the company's leadership, which aligns perfectly with the definition of Remuneration Information (DEF 14A), which covers compensation for top executives and directors. Although the document is in Dutch, the subject matter is clearly remuneration policy.
2024-03-22 Dutch
Remuneration Policy 2024_EN_FINAL.pdf
Remuneration Information Classification · 1% confidence The document is explicitly titled 'UCB Remuneration Policy 2024' and details the philosophy, principles, and specific compensation structures for both the Board members and the Executive Committee. This content directly relates to executive and director compensation practices. The definition for 'Remuneration Information' (Code: DEF 14A) is 'Report detailing compensation for top executives and directors.' Although the document is a policy, its core subject matter aligns perfectly with the DEF 14A category, which often encompasses the policy framework leading up to the annual vote on remuneration, rather than just the annual report of past compensation (which might be in the 10-K or a specific Remuneration Report). Given the specific focus on remuneration policy for executives and directors, DEF 14A is the most appropriate classification.
2024-03-22 English
UCB_SA_Report_KAM FR.pdf
Audit Report / Information Classification · 1% confidence The document is explicitly titled "Rapport du commissaire" (Auditor's Report) for the fiscal year ending 31.12.2023. It contains the auditor's opinion ("Opinion sans réserve") on the annual accounts, discusses key audit matters, and addresses other legal and regulatory obligations related to the annual report, as required by Belgian corporate law (Code des sociétés et des associations). This content structure is characteristic of a standalone Audit Report, which aligns with the definition for Code AR, rather than the full Annual Report (10-K) or a mere announcement of a report (RPA). Although it relates to the annual accounts, the document *is* the formal audit opinion/report itself. FY 2023
2024-03-22 French
NBB_UCB SA_31.12.2023_NL Final.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a formal Belgian 'Jaarrekening' (Annual Accounts) for UCB SA, covering the fiscal year 2023. It includes identification data, a list of directors, and detailed balance sheet tables. While it is part of the annual reporting process, it is specifically the statutory financial filing (Annual Accounts) rather than the narrative Annual Report (10-K). Given the structure and content, it falls under the category of an Interim/Quarterly Report (IR) equivalent for annual statutory filings, as it contains the actual financial statements. FY 2023
2024-03-22 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.